A novel, highly potent lipid nanoparticle (LNP) CRISPR-Cas9 delivery system targets the liver more efficiently than previous methods. Used in...
Lack of efficient delivery vehicles has so far hampered CRISPR-Cas9 editing in non-liver tumours. With a new lipid nanoparticle delivery system,...
All gene therapies have their own advantages and limitations, but one shared feature is the challenge in delivering the gene-editing or replacement...
The first clinical trial results indicate that CRISPR is a safe and beneficial gene editing tool in humans. However, full therapeutic translation of...
Continuous advances in gene editing technologies provide hopes for better therapies and cures for genetic diseases. However, a few obstacles remain,...
